Earlier this year, the FDA approved 2 new indications for Aquaflor. According to Merck, the supplemental approval increased ...

US stock futures edged higher Thursday ahead of a highly-anticipated speech by Fed chair Jerome Powell, which could provide ...

Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

Merck & Co. has struck a licensing deal with LaNova Medicines that is potentially worth more than $3 billion to the clinical-stage biotechnology company.

Kirby’s Rule of 20 is a list of 20 essential parameters that should be assessed daily in all critically ill animals. 1,2 In ...

Calvert Research and Management ranked the 100 most sustainable companies based on over 230 ESG indicators. Read here for our picks.

Stocks extended losses after Jerome Powell signaled the Federal Reserve is in no rush to cut rates as the economy is holding up.

(Bloomberg) — Stocks lost traction following a furious post-election rally that spurred calls for a breather amid signs of buyer fatigue. Equities fell from near all-time highs, with the S&P 500 ...